Skip to content

Inspection Record

Instituto Grifols, S.A. — FDA 483 Findings

US FDAInspected 2023-11-17Published 2026-10-27 5 findingsDeviation, CAPA, and investigationProcess validationComplaint and recall handlingStability and storage

Inspectors Susan M Jackson · Shafiq Ahadi · Natalya M Ananyeva and 1 moreThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Deviation, CAPA, and investigation

There is a failure to thoroughly review any unexplained discrepancy whether or not the batch has been already distributed.

2Process validation

Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality that they are purported or represented to possess.

3Complaint and recall handling

Procedures describing the handling of written and oral complaints related to drug products are deficiently written or followed.

4Deviation, CAPA, and investigation

Deviations from written production and process control procedures are not justified.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-27. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Instituto Grifols, S.A. company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.